Hence, the development of antagonists of the sulfatide/P-selectin interaction may benefit in the treatment of various pathophysiological conditions, such as acute coronary symptoms, which is underlined by the observation that sulfatides are attributed a role in P-selectin dependent neointima formation [26] and breast cancer progression [27]. This evidence concerns the gene SELP and breast cancer.